JNJoão Bueno Nunes

João Bueno Nunes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


João Bueno Nunes has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Optimization of the Chimeric Peptide Chim4 for Cell Selectivity and Proteolysis Stability

    by João B. Nunes, Bruno S. Sá, Guilherme H. S. Santos, Izadora C. M. Oliveira, Sonia M. Freitas, Marcelo H. S. Ramada, José R. S. A. Leite, Guilherme D. Brand

    Introduction: The rise of bacterial resistance has driven the search for new therapies, with antimicrobial peptides (AMPs) emerging as promising candidates

  • Open Access

    Modulation of Antioxidant Pathway by Bioactive Peptides: Impact on Post-Thaw Sperm Viability and Motility

    by Bruno S. Sá, Ana Gabriela P. Meneses, Sophia A. dos Reis, Natália P. B. Valadares, João B. Nunes, Pedro Paulo R. C. Melo, Andreanne G. Vasconcelos, José Roberto S. A. Leite

    Introduction: Sperm cryopreservation is a crucial advancement for fertility preservation—whether for social or clinical medical reasons—allowing for the postponement of gamete use and favoring reproductive planning

  • Open Access

    Antioxidant Activity and Cytotoxicity of Baru Nut Oil (Dipteryx alata Vogel) Nanoemulsion in Human Cells

    by José Queiroz, Arthur Figueredo, Bruno Silva Sá, Daniel Carneiro Moreira, João Bueno Nunes, Peter Eaton, José Roberto Souza de Almeida Leite, Andreanne Gomes Vasconcelos

    Baru nut oil (Dipteryx alata Vogel) is a lipidic extract from a species endemic to the Cerrado biome, renowned for its antioxidant potential. This study aimed to develop a nanoemulsion containing baru nut oil (BNON) using lecithin and polysorbate 80, and to evaluate its antioxidant activity and cytotoxicity. The physicochemical properties of BNON were characterized, and its cytotoxicity was assessed in human erythrocytes and keratinocytes. Antioxidant activity was evaluated using the DPPH method and inhibition of AAPH-induced hemolysis. BNON exhibited a droplet size of 530.1 ± 20.48 nm, a polydispersity index of 0.496 ± 0.057, and a zeta potential of −35.7 ± 2.19 mV. Free baru nut oil showed no cytotoxicity to keratinocytes or erythrocytes within the concentration ranges tested (1.0–0.031 mg/mL and 0.8–0.006 mg/mL, respectively). In contrast, BNON displayed cytotoxic effects on keratinocytes and erythrocytes only at the highest tested concentration. Atomic force microscopy analysis of erythrocytes from the hemolysis assay revealed normal morphology for cells treated with free oil at 0.8 mg/mL, whereas cells treated with BNON at the same concentration exhibited a slightly widened concave center. Free oil at 0.8 mg/mL significantly protected erythrocytes from AAPH-induced hemolysis, while BNON did not. However, BNON (5 mg/mL) demonstrated free radical scavenging activity, quantified at 0.0074 mg Trolox equivalents/mg via the DPPH assay. These findings suggest that baru nut oil has potential as an antioxidant product, although further optimization of the nanoformulation is required.


  • Open Access

    The Antioxidant Peptide Salamandrin-I: First Bioactive Peptide Identified from Skin Secretion of Salamandra Genus (Salamandra salamandra)

    by Alexandra Plácido, João Bueno, Eder A. Barbosa, Daniel C. Moreira, Jhones Do Nascimento Dias, Wanessa Felix Cabral, Patrícia Albuquerque, Lucinda J. Bessa, Jaime Freitas, Selma A. S. Kuckelhaus, et al.

    Amphibian skin is a multifunctional organ that plays key roles in defense, breathing, and water balance. In this study, skin secretion samples of the fire salamander (Salamandra salamandra) were separated using RP-HPLC and de novo sequenced using MALDI-TOF MS/MS. Next, we used an in silico platform to screen antioxidant molecules in the framework of density functional theory. One of the identified peptides, salamandrin-I, [M + H]+ = 1406.6 Da, was selected for solid-phase synthesis; it showed free radical scavenging activity against DPPH and ABTS radicals. Salamandrin-I did not show antimicrobial activity against Gram-positive and -negative bacteria. In vitro assays using human microglia and red blood cells showed that salamandrin-I has no cytotoxicity up to the concentration of 100 µM. In addition, in vivo toxicity tests on Galleria mellonella larvae resulted in no mortality at 20 and 40 mg/kg. Antioxidant peptides derived from natural sources are increasingly attracting interest. Among several applications, these peptides, such as salamandrin-I, can be used as templates in the design of novel antioxidant molecules that may contribute to devising strategies for more effective control of neurological disease.